Your browser doesn't support javascript.
loading
Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing onabotulinumtoxinA injection due to chronic intractable migraine?
Gandolfi, Marialuisa; Geroin, Christian; Valè, Nicola; Marchioretto, Fabio; Turrina, Andrea; Dimitrova, Eleonora; Tamburin, Stefano; Serina, Anna; Castellazzi, Paola; Meschieri, Andrea; Ricard, François; Saltuari, Leopold; Picelli, Alessandro; Smania, Nicola.
Afiliação
  • Gandolfi M; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy - marialuisa.gandolfi@univr.it.
  • Geroin C; UOC Neurorehabilitation, AOUI Verona, Verona, Italy - marialuisa.gandolfi@univr.it.
  • Valè N; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Marchioretto F; UOC Neurorehabilitation, AOUI Verona, Verona, Italy.
  • Turrina A; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Dimitrova E; UOC Neurorehabilitation, AOUI Verona, Verona, Italy.
  • Tamburin S; Unit of Neurology, Sacro Cuore Don Calabria Hospital, Verona, Italy.
  • Serina A; International Madrid School of Osteopathy, Italian Section, Verona, Italy.
  • Castellazzi P; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Meschieri A; UOC Neurorehabilitation, AOUI Verona, Verona, Italy.
  • Ricard F; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Saltuari L; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Picelli A; School of Specialization in Physical Medicine and Rehabilitation, University of Verona, Verona, Italy.
  • Smania N; School of Specialization in Physical Medicine and Rehabilitation, University of Verona, Verona, Italy.
Eur J Phys Rehabil Med ; 54(1): 1-12, 2018 Feb.
Article em En | MEDLINE | ID: mdl-28750504

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A / Manipulações Musculoesqueléticas / Pontos-Gatilho / Inibidores da Liberação da Acetilcolina / Transtornos de Enxaqueca / Síndromes da Dor Miofascial Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Phys Rehabil Med Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A / Manipulações Musculoesqueléticas / Pontos-Gatilho / Inibidores da Liberação da Acetilcolina / Transtornos de Enxaqueca / Síndromes da Dor Miofascial Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Phys Rehabil Med Ano de publicação: 2018 Tipo de documento: Article